TY - JOUR
T1 - Structural features and bioavailability of four flavonoids and their implications for lifespan-extending and antioxidant actions in C. elegans
AU - Grünz, Gregor
AU - Haas, Kerstin
AU - Soukup, Sebastian
AU - Klingenspor, Martin
AU - Kulling, Sabine E.
AU - Daniel, Hannelore
AU - Spanier, Britta
N1 - Funding Information:
Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR) . We thank Katrin Lasch and Ines Schmidts for technical assistance and the members of our working group for comments on the manuscript and helpful discussions. This research was supported by the Deutsche Forschungsgemeinschaft ( SP 965/3-1 ).
PY - 2012/1
Y1 - 2012/1
N2 - Various studies have demonstrated longevity effects of flavonoids, a major sub-group of plant polyphenolic compounds, in Caenorhabditis elegans. To better understand their structure-activity relationship in vivo we have used a comparative approach by exposing C. elegans to the structurally related flavonoids myricetin, quercetin, kaempferol and naringenin, and assessed their impact on lifespan and on putative modes of action. The bioavailability of the tested flavonoids was demonstrated by high-performance liquid chromatography with diode-array detection (HPLC/DAD) and a 2-aminoethyl diphenyl borate-based in vivo approach. While all flavonols increased lifespan in wild-type, only myricetin elongated the mev-1(kn1) lifespan, suggesting that the flavonols antioxidant action alone is not sufficient for longevity. Structural prerequisites of high antioxidant action in vitro were also essential to reduce the reactive oxygen species (ROS) load in vivo in C. elegans and were tested in isolated mouse muscle mitochondria. Since the insulin/IGF-like signaling (IIS) cascade is a key regulator of lifespan, all compounds were tested for the ability to cause nuclear translocation of the FOXO transcription factor DAF-16 and changes in target gene expression. An increased DAF-16 translocation and sod-3 promoter activity were observed with all flavonoids but was independent of their ROS scavenging capability and their effects on lifespan.
AB - Various studies have demonstrated longevity effects of flavonoids, a major sub-group of plant polyphenolic compounds, in Caenorhabditis elegans. To better understand their structure-activity relationship in vivo we have used a comparative approach by exposing C. elegans to the structurally related flavonoids myricetin, quercetin, kaempferol and naringenin, and assessed their impact on lifespan and on putative modes of action. The bioavailability of the tested flavonoids was demonstrated by high-performance liquid chromatography with diode-array detection (HPLC/DAD) and a 2-aminoethyl diphenyl borate-based in vivo approach. While all flavonols increased lifespan in wild-type, only myricetin elongated the mev-1(kn1) lifespan, suggesting that the flavonols antioxidant action alone is not sufficient for longevity. Structural prerequisites of high antioxidant action in vitro were also essential to reduce the reactive oxygen species (ROS) load in vivo in C. elegans and were tested in isolated mouse muscle mitochondria. Since the insulin/IGF-like signaling (IIS) cascade is a key regulator of lifespan, all compounds were tested for the ability to cause nuclear translocation of the FOXO transcription factor DAF-16 and changes in target gene expression. An increased DAF-16 translocation and sod-3 promoter activity were observed with all flavonoids but was independent of their ROS scavenging capability and their effects on lifespan.
KW - Antioxidant capacity
KW - Flavonoid bioavailability
KW - Insulin/IGF-like signaling
KW - Longevity
KW - Reactive oxygen species
UR - http://www.scopus.com/inward/record.url?scp=84856230501&partnerID=8YFLogxK
U2 - 10.1016/j.mad.2011.11.005
DO - 10.1016/j.mad.2011.11.005
M3 - Article
C2 - 22155175
AN - SCOPUS:84856230501
SN - 0047-6374
VL - 133
SP - 1
EP - 10
JO - Mechanisms of Ageing and Development
JF - Mechanisms of Ageing and Development
IS - 1
ER -